SEMA3A and autoimmune disease: In the co-culture of Sema3A with Treg cells, there was an increase in the number of Treg cells and an improvement in their function, suggesting that Sema3A may represent a promising new therapeutic strategy for treating autoimmune diseases [12,13,14].